Evidence map›Paper›PMID 40028101›Full record

ArticleACS omega2025

Rapid, Economical Detection of

Jiaye Jiang, Mathias Charconnet, Ana Galvez Vergara, Shixi Zhang, Yuhan Zhang, Yu Liang, Javier Zubiria, Ane Sorarrain, Jose M Marimon, Yuan Peng and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jiaye JiangCollege of Sciences, Shanghai University, Shanghai 201800, China.
Mathias CharconnetSino-Swiss Institute of Advanced Technology (SSIAT) Shanghai University, Shanghai 201800, China.
Ana Galvez VergaraSino-Swiss Institute of Advanced Technology (SSIAT) Shanghai University, Shanghai 201800, China.
Shixi ZhangSino-Swiss Institute of Advanced Technology (SSIAT) Shanghai University, Shanghai 201800, China.
Yuhan ZhangSino-Swiss Institute of Advanced Technology (SSIAT) Shanghai University, Shanghai 201800, China.
Yu LiangShanghai Indicate Biotech, Shanghai 200444, China.
Javier ZubiriaSino-Swiss Institute of Advanced Technology (SSIAT) Shanghai University, Shanghai 201800, China.
Ane SorarrainRespiratory Infection and Antimicrobial Resistance Group, Biogipuzkoa Health Research Institute, Donostia-San Sebastian 20014, Spain.
Jose M MarimonRespiratory Infection and Antimicrobial Resistance Group, Biogipuzkoa Health Research Institute, Donostia-San Sebastian 20014, Spain.
Yuan PengSino-Swiss Institute of Advanced Technology (SSIAT) Shanghai University, Shanghai 201800, China.
Lei ZhangSino-Swiss Institute of Advanced Technology (SSIAT) Shanghai University, Shanghai 201800, China.
Charles H LawrieSino-Swiss Institute of Advanced Technology (SSIAT) Shanghai University, Shanghai 201800, China.ORCID https://orcid.org/0000-0002-8882-1131

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nucleic acid tests (NAT), the gold standard diagnostic technology, play a crucial role in the prevention of infectious diseases. However, PCR, the current state-of-the-art NAT, is expensive, slow, and requires dedicated infrastructure and facilities. Therefore, there exists an urgent need to create alternative molecular diagnostic technologies. We describe the use of a gold colloidal nanobiosensor detection system that can specifically and sensitively detect the 16S rRNA gene of the worldwide gastric pathogen

Identifiers

PMID40028101
PMCPMC11866199

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.